(Q37875564)

24 August 2017

1 reference

title

Eight-year (2002-2009) summary of the linezolid (Zyvox® Annual Appraisal of Potency and Spectrum; ZAAPS) program in European countries (English)

1 reference

24 August 2017

1 reference

5

Jones RN

1 reference

24 August 2017

Ross JE

1

1 reference

24 August 2017

Farrell DJ

series ordinal

2

1 reference

24 August 2017

Mendes RE

series ordinal

3

1 reference

24 August 2017

Sader HS

series ordinal

4

1 reference

24 August 2017

1 April 2011

1 reference

24 August 2017

Journal of Chemotherapy

1 reference

24 August 2017

23

1 reference

24 August 2017

2

1 reference

24 August 2017

71-76

1 reference

Trends in linezolid susceptibility patterns: report from the 2002-2003 worldwide Zyvox Annual Appraisal of Potency and Spectrum (ZAAPS) Program

24 August 2017

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2011.23.2.71

Stability of linezolid activity in an era of mobile oxazolidinone resistance determinants: results from the 2009 Zyvox® Annual Appraisal of Potency and Spectrum program

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2011.23.2.71

Oxazolidinone susceptibility patterns in 2004: report from the Zyvox Annual Appraisal of Potency and Spectrum (ZAAPS) Program assessing isolates from 16 nations

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2011.23.2.71

Zyvox Annual Appraisal of Potency and Spectrum Program Results for 2006: an activity and spectrum analysis of linezolid using clinical isolates from 16 countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2011.23.2.71

ZAAPS International Surveillance Program (2007) for linezolid resistance: results from 5591 Gram-positive clinical isolates in 23 countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2011.23.2.71

Zyvox Annual Appraisal of Potency and Spectrum program: linezolid surveillance program results for 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2011.23.2.71

Trends in linezolid susceptibility patterns in 2002: report from the worldwide Zyvox Annual Appraisal of Potency and Spectrum Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2011.23.2.71

Oxazolidinone susceptibility patterns for 2005: International Report from the Zyvox Annual Appraisal of Potency and Spectrum Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2011.23.2.71

Linezolid versus vancomycin for the treatment of gram-positive bacterial infections: meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2011.23.2.71

Efficacy and safety of linezolid in methicillin-resistant Staphylococcus aureus (MRSA) complicated skin and soft tissue infection (cSSTI): a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2011.23.2.71

Oxazolidinone antibiotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2011.23.2.71

Linezolid: the first oxazolidinone antimicrobial

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2011.23.2.71

Crystal structure of the oxazolidinone antibiotic linezolid bound to the 50S ribosomal subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2011.23.2.71

The Cfr rRNA methyltransferase confers resistance to Phenicols, Lincosamides, Oxazolidinones, Pleuromutilins, and Streptogramin A antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2011.23.2.71

First report of cfr-mediated resistance to linezolid in human staphylococcal clinical isolates recovered in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2011.23.2.71

Multicentre assessment of linezolid antimicrobial activity and spectrum in Europe: report from the Zyvox antimicrobial potency study (ZAPS-Europe).

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2011.23.2.71

Linezolid surveillance program results for 2008 (LEADER Program for 2008).

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2011.23.2.71

Nosocomial outbreak of linezolid-resistant Enterococcus faecalis infection in a tertiary care hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2011.23.2.71

Dissemination of two international linezolid-resistant Staphylococcus epidermidis clones in Greek hospitals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2011.23.2.71

Resistance to linezolid is mediated by the cfr gene in the first report of an outbreak of linezolid-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2011.23.2.71

Linezolid-resistant Enterococcus faecium isolated from a patient without prior exposure to an oxazolidinone: report from the SENTRY Antimicrobial Surveillance Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2011.23.2.71

21 January 2018

Identifiers

DOI

10.1179/JOC.2011.23.2.71

1 reference

24 August 2017

1 reference